Using a physiological approach to breast cancer detection allows for more specific evaluations and improved management of challenging cases. Breast-Specific Gamma Imaging (BSGI) is a molecular study of the breast that provides physiological data not available from any other imaging modality- helping to quickly determine the nature of suspicious lesions, and in many cases- the extent of disease.

From a surgical perspective, the benefits of BSGI with the Dilon 6800 are many:

• High positive & negative Predictive values: 68 & 99% respectively.
• Image lesions as small as 3 mm
  • For all breast carcinomas, very high sensitivity
  • For DCIS and lobular carcinomas, excellent sensitivity
• Evaluate extent of disease for breast conservation surgery
  • Primary lesion size
  • Multicentricity and/or multifocality
  • Axillary node evaluation
• MIMIC ALL MAMMOGRAPHIC VIEWS FOR EASY IMAGE CORRELATION
  • Helps localize area of interest
• INDICATIONS: dense breasts, augmented, post-radiation, multiple areas of interest, and palpable lesions occult in other modalities
• Helps evaluate need for biopsy ~ Specificity of 92%
• Neoadjuvant Chemotherapy Guidance
  • Prediction of response
  • Monitoring of response